ScholarLens Back to search
2013•China Modern DoctorRequires access

Mecobalamin alprostadil treatment of diabetic peripheral neuropathy clinical observation

Gao Jinheng

Open publisher page 0 citations

Abstract

Objective To observe the mecobalamin combined alprostadil improved the symptoms of diabetic peripheral neuropathy.Methods All of 90 patients with diabetic peripheral neuropathy were randomly divided into a treatment group and the control group,the treatment group 50 cases the Mecobalamin alprostadil treatment;control group of 40 patients with mecobalamin;two weeks for a course.Results After treatment,the treatment of patients with neurological symptoms and TSS score were better than those in control group.Conclusion Methylcobalamin alprostadil combination than alone Methylcobalamin treatment of diabetic peripheral neuropathy.

About this research paper

What this paper is about

Objective To observe the mecobalamin combined alprostadil improved the symptoms of diabetic peripheral neuropathy.Methods All of 90 patients with diabetic peripheral neuropathy were randomly divided into a treatment group and the control group,the treatment group 50 cases the Mecobalamin alprostadil treatment;control group of 40 patients with mecobalamin;two weeks for a course.Results After treatment,the treatment of patients with neurological symptoms and TSS score were better than those in control group.Conclusion Methylcobalamin alprostadil combination than alone Methylcobalamin treatment of diabetic peripheral neuropathy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the mecobalamin combined alprostadil improved the symptoms of diabetic peripheral neuropathy.Methods All of 90 patients with diabetic peripheral neuropathy were randomly divided into a treatment group and the control group,the treatment group 50 cases the Mecobalamin alprostadil treatment;control group of 40 patients with mecobalamin;two weeks for a course.Results After treatment,the treatment of patients with neurological symptoms and TSS score were better than those in control group.Conclusion Methylcobalamin alprostadil combination than alone Methylcobalamin treatment of diabetic peripheral neuropathy.

Key concepts: Medicine, Methylcobalamin, Peripheral neuropathy, Peripheral, Diabetes mellitus, Surgery, Internal medicine, Vitamin B12

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Mecobalamin alprostadil treatment of diabetic peripheral neuropathy clinical observation — Research Paper | ScholarLens